Showing results (1-10 of 126) with videos related to

Sort By:
Pageof 13
Pharmacogenomics|July 20, 2007
Pharmacology, pharmacokinetics and pharmacogenomics of paclitaxelHelen Steed, Michael B Sawyer
Critical Reviews in Oncology/Hematology|November 10, 2006
Pharmacogenetics of paclitaxel metabolismJennifer Spratlin, Michael B Sawyer
Expert Review of Clinical Pharmacology|June 27, 2017
A review of body composition and pharmacokinetics in oncologyJessica J Hopkins, Michael B Sawyer
Biologics : Targets & Therapy|July 19, 2012
Metastatic gastric cancer - focus on targeted therapiesJudith Meza-Junco, Michael B Sawyer
Cancer Chemotherapy and Pharmacology|June 8, 2018
Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatmentsJessica J Hopkins, Michael B Sawyer
Biomarkers in Medicine|May 19, 2010
Drug exposure: still an excellent biomarkerJudith Meza-Junco, Michael B Sawyer
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 27, 2020
Tolerability of pemetrexed and oxaliplatin in the treatment of stage III colon cancer during raltitrexed shortageJasmine Giani, Michael B Sawyer, Carole Chambers
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|September 27, 2021
Case report: Proton pump inhibitor drug-related problem in pancreatic cancer patient unmasks pancreatic enzyme insufficiencyJasmine Giani, Carole R Chambers, Michael B Sawyer
Rapid Communications in Mass Spectrometry : RCM|August 1, 2006
Mass spectrometry study of hemoglobin-oxaliplatin complexes in colorectal cancer patients and potential association with chemotherapeutic responsesRupasri Mandal, Michael B Sawyer, Xing-Fang Li
Pageof 13